The stock of Healthpeak Properties Inc. (NYSE:PEAK) decreased by -$0.32 on Tuesday to finish at $20.33, down -1.55 percent. The last five days have seen an average of 2,672,420 shares of common stock traded. 9 times new highs were reached in the current year, with a fall of -$4.74. The average number of shares traded over the last 20 days was 3,689,120, while the average volume over the last 50 days totaled 4,409,730.
PEAK stock dropped -3.97% since last month. On 08/15/23, the company’s shares reached a one-month low of $20.23. The stock touched a high of $28.43 on 02/02/23, after rallying from a low of $19.08 in 52 weeks. The price of PEAK stock has declined by -18.91% or -$4.74 this year, reaching a new high 9 times. Still, the stock price is down -28.49% from the 52-week high.
Insider Transactions
PEAK stock investors should be aware that Healthpeak Properties Inc. (PEAK) stock had its last reported insider trading activity 154 days ago on Mar 15. On Mar 15, Director Lewis Sara Grootwassink acquired 4,000 shares at $21.43 each. This transaction resulted in the insider spending $85,729. On Mar 07, Klaritch Thomas added 1,517 shares at a price of US$23.21. After the transaction, the insider now owns 344,000 shares. President and CEO Brinker Scott M had earlier bought 16,300 shares on Mar 02 for $23.63 a share. The transaction was completed for $385,169.
Valuation Metrics
Healthpeak Properties Inc. (PEAK) has a trailing price-to-earnings (P/E) ratio of 20.96. Beta for the stock is 0.88. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 5.27, the price-to-book (PB) ratio of 1.68, and the price-to-cash flow ratio of 64.45.
Company paid $0.30 per share in dividends, remained unchanged from $0.30 last year. A $0.07 dividend decrease was reported on Wednesday February 10 2021.
Financial Health
The company’s long-term debt to equity ratio for the quarter ending June 29 is 0.96, and the total debt to equity ratio is 0.98. As far as profitability goes, gross margin for the trailing twelve months is 58.50% percent. Healthpeak Properties Inc.’s operating margin stood at 31.00% for the same period. Based on annual data, it had gross profit of $344.73 million and revenue of $2.06 billion.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. PEAK’s return on assets (ROA) during the last 12 months has been 3.20%. There was a 5.00% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 7.60%.
Earnings Surprise
According to Healthpeak Properties Inc.’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $545.43 million, while revenues rose by 5.04% to $525.68 million. It was predicted that Healthpeak Properties Inc.’s quarterly earnings would be $0.09, but it ended up being $0.11, beating the consensus by -18.20%. EBITDA was $268.15 million for the quarter. At the end of Healthpeak Properties Inc.’s most recent quarter ended June 29, its total debt was $6.77 billion. Equity owned by shareholders amounts to $547.05 million.
Technical Picture
Here’s a quick look at Healthpeak Properties Inc.’s (PEAK) price momentum from a technical perspective. As of 15 August, the RSI 9-day stood at 26.71%, suggesting the stock is oversold, with a 14.57% historical volatility rate.
The stochastic %K and %D were 5.29% and 7.63% respectively, while the average true range (ATR) was 0.44. Based on the 14-day stochastic reading of 4.87%, the RSI (14) reading is 35.80%. On the 9-day MACD Oscillator, the stock is at -0.40, and the 14-day reading is at -0.66.
Analyst Ratings
In its most recent analyst report, Mizuho raised its rating on Healthpeak Properties Inc. (NYSE: PEAK) to a Buy. Prior to this, analysts firm rated the stock as a Neutral. Analysts have assigned Healthpeak Properties Inc. (PEAK) an Overweight rating. PEAK is a stock that is recommended for selling by 0 brokerage firms, while 8 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 3 rates it overweight and 8 others recommend it as a buy.
What is PEAK’s price target for the next 12 months?
The current consensus forecast for the stock is between $22.00 and $32.00, with a median target price of $25.00. In analyzing these forecasts, the average price target given by analysts for Healthpeak Properties Inc. (PEAK) is $25.53.
